Cover Image
市場調查報告書

全球Omega-3脂肪酸產品市場:各類型、用途、地區(2017年∼2022年)

Global Omega-3 Product Market - Segmented by Type, Application, and Geography (2017 - 2022)

出版商 Mordor Intelligence LLP 商品編碼 572854
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球Omega-3脂肪酸產品市場:各類型、用途、地區(2017年∼2022年) Global Omega-3 Product Market - Segmented by Type, Application, and Geography (2017 - 2022)
出版日期: 2017年08月01日 內容資訊: 英文 100 Pages
簡介

Omega-3脂肪酸產品市場,主要以二十碳五烯酸(EPA)和二十二碳六烯酸(DHA)為基礎的產品構成。營養補充品市場成長,及開發中國家的嬰兒用配方奶粉的龐大需求成為這個市場的成長要素。

本報告提供Omega-3脂肪酸的全球市場調查,市場概要,各類型、用途、濃度、地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等,全面的資訊。

目錄

第1章 簡介

  • 主要調查結果
  • 調查的前提條件
  • 市場定義

第2章 調查方法

  • 簡介
  • 調查計劃
  • 調查的時間軸
  • 調查的階段
    • 2次調查
    • 討論指南
    • 市場工程與計量經濟學建模

第3章 市場概要

  • 市場趨勢
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 波特的五力分析

第4章 市場區隔

  • 各類型
    • 二十碳五烯酸(EPA)
    • 二十二碳六烯酸(DHA)
  • 各濃度類型
    • 高濃縮類型
    • 濃縮類型
    • 低濃縮類型
  • 各用途
    • 嬰兒用配方奶粉
    • 營養強化食品、飲料
    • 臨床營養、醫藥品
    • 減肥補給品
    • 醫藥品
    • 動物營養
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 非洲

第5章 競爭情形

  • 主要企業的策略
  • 過去5年最活躍的企業
  • 市場佔有率分析

第6章 企業簡介

  • DSM NUTRITIONAL PRODUCTS
  • BIOPROCESS ALGAE LLC
  • Cargill Incorporated (US)
  • SOURCE-OMEGA
  • QUALITAS HEALTH
  • NORDIC NATURALS
  • ADM
  • ALGAECYTES
  • SIMRIS ALG
  • Algisys
  • FMC Corporation (US)
  • TerraVia (Solazyme)
  • Croda International PLC (UK)
  • Nature's Way (Ascenta Health)

第7章 附錄

  • 免責聲明
  • 參考資料
目錄

The Global Omega-3 product market was valued at USD 34.1 billion in 2015 and is projected to reach USD XX billion by 2022, registering a CAGR of XX% during the forecast period of 2017-2022. Omega-3 products consist of Eicosapentanoic acid (EPA) and Docosahexanoic acid (DHA) based products.

Royal DSM and Evonik announced a joint venture for production of omega-3 fatty acid from marine algae in March, 2017. This joint venture value is around USD 200 million (each will contribute for USD 100 million), and each of them hold a 50% share. It is estimated that the initial annual production capacity will be sufficient to capture roughly 15% of the total annual demand for omega 3 fatty acid industry. This joint venture will come to the market with a name as Veramaris in The Netherland.

GROWING FUNCTIONAL FOOD = OMEGA-3 PRODUCT DEMAND:

The global Omega-3 product market is being dominantly driven by the strong demand of infant formula products, in developing regions, such as China. The Omega-3 demand is growing at a faster rate in infant food fortification, as it provides the essential DHA for infant brain development. In addition, the global dietary supplement market is growing at a quick pace, which has further increased the demand of Omega-3 supplements. However, the major restraint for the market is the depleting fish population, the primary source of Omega-3. The other marine sources of Omega-3 are - krill oil, algae oil, other than fish. Algae sourced Omega-3 is the fastest growing segment, due to various factors. Omega-3 obtained from algae are considered as more bioavailable and sustainable for production, which are key considerations in the present scenario, where overfishing is a major problem. Another benefit associated with algae Omega-3 is that, it is suitable for the vegetarian label. Moreover, the product quality of algae Omega-3 is superior as compared to fish oil, because it is free from any toxic pollutants, in addition to high purity in terms of form of fatty acid, and off sensory properties. Another major restraining factor for the market growth is the high cost of product, due to higher downstream processing cost. However, with passage of time and due to technological advancements, its price is forecasted to reduce, which can make the product highly competitive.

INFANT FORMULA CONSUMPTION GROWING AT A FAST PACE:

The market has been segmented based on type, concentration type, application type, and geography. Commercially, there are two types of essential Omega-3 fatty acids - Eicosapentanoic acid (EPA) and Docosahexanoic acid (DHA). DHA holds the largest share in the market, due to its high demand in infant formula products and legal recommendations. EPA-based products are the fastest growing segments, supported by the various health benefits, which has increased its importance in drug formulation. Based on concentration type, the market is divided into high concentrated, concentrated, and low concentrated products. Currently, low concentrated and concentrated Omega-3 products are capturing the market. The growing awareness among consumers regarding the daily dosage of Omega-3 has focused the demand of high concentrated products. Based on application, the market is segmented into infant formula, dietary supplements, fortified food & beverages, clinical nutrition and medical foods, pharmaceuticals, and animal nutrition. The infant formula segment is poised to grow with a CAGR of 8.2% during the forecast period. Animal nutrition is anticipated to be another major growing segment, due to increased health concern among pet owners.

GEOGRAPHIC COMPETITION:

The global Omega-3 product market has been divided into North America, Europe, Asia-Pacific, South America, and Africa. Asia- Pacific is the fastest growing region, due to growing fortified food demand and increased consumer awareness. Japan and China are the significant markets in Asia- Pacific, captured by key domestic players. Asia-Pacific holds the major share in the Omega-3 product market, due to high infant formula consumption, followed by North America with a share of 32%. South America is another growing consumer of Omega-3 fatty acid, driven by the high consumption of fortified products.

MAJOR PLAYERS:

  • DSM Nutritional Products
  • Cargill Incorporated (US)
  • FMC Corporation (US)
  • Croda International PLC (UK)
  • Terravia (Solazyme)
  • Qualitas Health

NOTABLE MARKET DEVELOPMENTS:

  • 1. Bio process algae has signed an agreement with KD Pharma, to supply EPA rich Omega oil from algae.
  • 2. DSM and Evonik established a joint venture for omega-3 fatty acids, from natural marine algae for animal nutrition.

Our report on the global Omega-3 product market covers the following

  • MRO Market Trends & Dynamics
  • Latest News & developments
  • Porter's Five Force Analysis
  • Investment Scope
  • Deep-Dive Insights

Table of Contents

1. Introduction

  • 1.1. Key Deliverables of the Study
  • 1.2. Study Assumptions
  • 1.3. Market Definitions

2. Research Approach and Methodology

  • 2.1. Introduction
  • 2.2. Research Design
  • 2.3. Study timelines
  • 2.4. Study Phases
    • 2.4.1. Secondary Research
    • 2.4.2. Discussion Guide
    • 2.4.3. Market Engineering & Econometric Modelling
    • 2.4.4. Expert Validation

3. Market Overview

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
      • 3.1.1.1. Increased Demand for Infant Formula Products in Developing Regions
      • 3.1.1.2. Growing Demand for Sustainable Sources of Omega-3 Fatty Acid Suitable for Vegetarian Label
      • 3.1.1.3. Increasing Demand for Omega-3 in Functional Foods & Pharmaceuticals
    • 3.1.2. Restraints
      • 3.1.2.1. Depleting Fish Oil Concentration Worldwide
      • 3.1.2.2. Higher Downstream Processing Cost
    • 3.1.3. Opportunities
      • 3.1.3.1. Growing Demand for Algae EPA in Drug Applications
    • 3.1.4. Porter's Five Forces Analysis
      • 3.1.4.1. Bargaining Power of Suppliers
      • 3.1.4.2. Bargaining Power of Buyers
      • 3.1.4.3. Threat of New Entrants
      • 3.1.4.4. Threat of Substitute Products and Services
      • 3.1.4.5. Degree of Competition

4. Market Segmentation

  • 4.1. By Type
    • 4.1.1. Eicosapentanoic acid (EPA)
    • 4.1.2. Docosahexanoic acid (DHA)
  • 4.2. By Concentration Type
    • 4.2.1. High Concentrated
    • 4.2.2. Concentrated
    • 4.2.3. Low Concentrated
  • 4.3. By Application
    • 4.3.1. Infant Formula
    • 4.3.2. Fortified Food & Beverages
    • 4.3.3. Clinical Nutrition and Medical Foods
    • 4.3.4. Dietary Supplement
    • 4.3.5. Pharmaceuticals
    • 4.3.6. Animal Nutrition
  • 4.4. By Geography
    • 4.4.1. North America
      • 4.4.1.1. United States
      • 4.4.1.2. Canada
      • 4.4.1.3. Mexico
      • 4.4.1.4. Others
    • 4.4.2. Europe
      • 4.4.2.1. Spain
      • 4.4.2.2. United Kingdom
      • 4.4.2.3. France
      • 4.4.2.4. Germany
      • 4.4.2.5. Russia
      • 4.4.2.6. Italy
      • 4.4.2.7. Others
    • 4.4.3. Asia-Pacific
      • 4.4.3.1. China
      • 4.4.3.2. India
      • 4.4.3.3. Japan
      • 4.4.3.4. Australia
      • 4.4.3.5. Others
    • 4.4.4. South America
      • 4.4.4.1. Brazil
      • 4.4.4.2. Argentina
      • 4.4.4.3. Others
    • 4.4.5. Africa
      • 4.4.5.1. South Africa
      • 4.4.5.2. Others

5. Competitive Landscape

  • 5.1. Strategies Adopted by Key players
  • 5.2. The Most Active Companies in the Past Five Years
  • 5.3. Market Share Analysis

6. Company Profiles

  • 6.1. DSM NUTRITIONAL PRODUCTS
  • 6.2. BIOPROCESS ALGAE LLC
  • 6.3. Cargill Incorporated (US)
  • 6.4. SOURCE-OMEGA
  • 6.5. QUALITAS HEALTH
  • 6.6. NORDIC NATURALS
  • 6.7. ADM
  • 6.8. ALGAECYTES
  • 6.9. SIMRIS ALG
  • 6.10. Algisys
  • 6.11. FMC Corporation (US)
  • 6.12. TerraVia (Solazyme)
  • 6.13. Croda International PLC (UK)
  • 6.14. Nature's Way (Ascenta Health)

7. Appendix

  • 7.1. Disclaimer
  • 7.2. Sources
Back to Top